Beta Bionics, Inc.
Develops and commercializes automated insulin delivery systems for diabetes management.
BBNX | US
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 11 HUGHES, 92618 IRVINE
- Website:
- https://www.betabionics.com
- Sector:
- Manufacturing
Description
Beta Bionics, Inc. is a commercial-stage medical technology company that designs, develops, and commercializes solutions for diabetes management. Its flagship product is the iLet Bionic Pancreas, a fully automated insulin delivery system. The iLet uses an adaptive, learning algorithm to autonomously determine and deliver 100% of insulin doses based on data from a compatible continuous glucose monitor (CGM), such as the Dexcom G7 or Abbott FreeStyle Libre 3 Plus. The system is designed for people aged six and older with type 1 diabetes, aiming to reduce the burden of management by eliminating the need for manual carb counting and insulin correction calculations.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Beta Bionics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Beta Bionics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Beta Bionics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
